Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed

Author： Avallone Antonio Gennaro Elena Di Silvestro Lucrezia Iaffaioli Vincenzo Rosario Budillon Alfredo

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.1, 2014-01, pp. : 113-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G>C SNP of thymidylate synthase with respect to colorectal cancer

By Gusella Milena Padrini Roberto

Pharmacogenomics, Vol. 8, Iss. 8, 2007-08 ,pp. : 985-996

Future Medicine

Access to resources Recommend Favorite

Intratumoural Thymidylate Synthase and Dihydropyrimidine Dehydrogenase Activities Are Good Predictors of 5-Fluorouracil Sensitivity in Colorectal Cancer

By Ishibiki Y Kitajima M Sakamoto K Tomiki Y Sakamoto S Kamano T

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 181-187

Field House Publishing

Access to resources Recommend Favorite

Inferior QOL effect with raltitrexed for colorectal cancer

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

By Cao Shousong Bhattacharya Arup Durrani Farukh A Fakih Marwan

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 687-703

Informa Healthcare

Access to resources Recommend Favorite

Inferior QOL effect with raltitrexed for colorectal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite